Gm410 Activators
Ankub1 activators constitute a diverse group of chemical agents that modulate the activity of ankyrin repeat and ubiquitin domain containing 1 (ANKUB1), a protein implicated in the ubiquitination process. Ubiquitination is a cellular mechanism that tags proteins for degradation, thereby maintaining protein homeostasis within cellular environments. The activators of ANKUB1 span a broad spectrum of molecular structures and engage with various biochemical pathways to exert their influence on the functional dynamics of ANKUB1. These compounds are recognized for their ability to indirectly stimulate the ubiquitin ligase activity of ANKUB1, which is pivotal for tagging unwanted or damaged proteins with ubiquitin. This tagging process is a critical element of the protein quality control system within cells, ensuring the degradation of proteins that may otherwise accumulate and disrupt cellular functions.
Some activators, such as forskolin, work by elevating intracellular cyclic AMP (cAMP) levels, leading to the activation of protein kinase A (PKA). PKA, in turn, phosphorylates specific substrates that can interact with ANKUB1, thereby potentially enhancing its ubiquitin ligase activity. Other chemicals, such as phorbol 12-myristate 13-acetate (PMA), activate protein kinase C (PKC), which phosphorylates proteins that form part of the regulatory framework within which ANKUB1 operates. Additionally, agents that modulate intracellular calcium levels, such as ionomycin and Bay K8644, activate calcium-dependent kinases. These kinases can also phosphorylate regulatory proteins associated with ANKUB1's activity, thereby influencing its function. The chemical landscape of ANKUB1 activators is further diversified by compounds that inhibit specific enzymes or cellular processes, leading to an increase in the availability of substrates for ubiquitination, or by stabilizing proteins that interact with ANKUB1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). PKC can phosphorylate regulatory proteins that influence the function of ankyrin repeat and ubiquitin domain containing 1, enhancing its activity by facilitating its role in protein ubiquitination. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin increases intracellular calcium levels, which activates calmodulin-dependent protein kinases (CaMK). Activation of CaMK can lead to phosphorylation events that may indirectly enhance the activity of ankyrin repeat and ubiquitin domain containing 1 by modifying proteins that regulate its ubiquitin ligase activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 can stabilize proteins involved in the Wnt signaling pathway, which may interact with ankyrin repeat and ubiquitin domain containing 1, leading to enhanced ubiquitination activity related to this pathway. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins. This accumulation could indirectly increase the demand for ankyrin repeat and ubiquitin domain containing 1 activity by enhancing the necessity for its function in the protein degradation pathway. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin is a selective proteasome inhibitor that leads to the accumulation of ubiquitinated proteins. This accumulation can increase the functional activity of ankyrin repeat and ubiquitin domain containing 1 by indirectly enhancing its role in the ubiquitin-proteasome system. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 acts as a calcium channel agonist, which can increase intracellular calcium levels and potentially activate calmodulin-dependent kinases. These kinases may then phosphorylate regulatory proteins that influence the activity of ankyrin repeat and ubiquitin domain containing 1, thereby enhancing its ubiquitin ligase function. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 is a ubiquitin-activating enzyme E1 inhibitor. By inhibiting upstream steps of the ubiquitination cascade, PYR-41 can indirectly enhance the ubiquitin ligase activity of ankyrin repeat and ubiquitin domain containing 1 by preventing the depletion of the ubiquitin pool available for its ligase activity. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to inhibit lysosomal function and autophagy. This inhibition can lead to an increase in protein substrates within the cell, which may indirectly enhance the activity of ankyrin repeat and ubiquitin domain containing 1 by increasing the need for its role in protein ubiquitination. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 inhibits the NEDD8-activating enzyme, which is crucial for the neddylation process that regulates ubiquitin ligase activity. Inhibition of neddylation can result in increased ankyrin repeat and ubiquitin domain containing 1 activity by stabilizing proteins that would normally be neddylated and targeted for degradation, thus enhancing its ubiquitination function. | ||||||